Clinical Trials Directory

Trials / Completed

CompletedNCT03351556

Optimizing the Efficiency and Implementation of Cash Transfers to Improve Adherence to Antiretroviral Therapy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
530 (actual)
Sponsor
University of California, Berkeley · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

1. Determine the "dose-response" relationship between a cash transfer amount and HIV viral suppression at 6 months 2. Identify the most effective cash transfer size to increase the proportion of people living with HIV infection (PLHIV) retained in care and with suppressed viral load (\<1000 copies/ml) after 6 months. (This amount will be further evaluated in a cluster randomized trial in Phase 2).

Detailed description

Participants in the control group will receive the standard HIV primary care services according to Tanzania's National Guidelines for the Management of HIV and AIDS. The study has two active intervention arms: 1. The opportunity to earn 10,000 TZS/month (\~$4.50) for up to 6 months conditional on visit attendance, and 2. The opportunity to earn 22,500 TZS/month (\~$10.00) for up to 6 months conditional on visit attendance In both intervention arms, cash transfers will be delivered a maximum of once monthly, spaced ≥28 days apart, for up to six months and delivered via an automatic mobile money system linked to a biometric identification system.

Conditions

Interventions

TypeNameDescription
BEHAVIORALActive Arm 1Participants in this arm will receive the standard HIV primary care services according to Tanzania's National Guidelines for the Management of HIV and AIDS plus the opportunity to earn 10,000 TZS/month conditional on visit attendance.
BEHAVIORALActive Arm 2Participants in this arm will receive the standard HIV primary care services according to Tanzania's National Guidelines for the Management of HIV and AIDS plus the opportunity to earn 22,500 TZS/month conditional on visit attendance.

Timeline

Start date
2018-04-24
Primary completion
2019-06-30
Completion
2019-06-30
First posted
2017-11-24
Last updated
2022-08-22

Locations

4 sites across 1 country: Tanzania

Source: ClinicalTrials.gov record NCT03351556. Inclusion in this directory is not an endorsement.